DCVC Opportunity Fund II GP, LLC

Est. AUM

$13.9M

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	Recursion Pharmaceuticals, Inc.	CL A	$12.1M	3951141	87.48%	SOLE
2	IonQ, Inc.	CL A	$1.7M	60226	12.52%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.